Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065131102> ?p ?o ?g. }
- W2065131102 endingPage "300" @default.
- W2065131102 startingPage "293" @default.
- W2065131102 abstract "The plasma levels and tissue penetration of pefloxacin were studied after prophylactic administration to patients undergoing elective biliary surgery. Pefloxacin was administered as a single dose of 800 mg given intravenously as an infusion 1 h before surgery. Over a period of two years, cultures of bile and stone were performed after cholecystectomy in order to find the main pathogens present in the geographical area of the hospital of Txagorritxu (Vitoria, Spain), as well as to test the antimicrobial susceptibility of these bacteria to pefloxacin. Thirty seven per cent of the bile and stone cultures were positive, and 75 different species were isolated. E. coli was the predominant microorganism (25%). Other frequent microorganisms were E. faecium (9.3%), S. epidermidis (6.6%) and Cl. perfringens (6.6%). Most species isolated were susceptible to pefloxacin, with MIC(90) values of 0.125 microg/ml for E. coli, 0.5 microg/ml for S. epidermidis and 1 microg/ml for Cl. perfringens. E. faecium was resistant, with a MIC(90) value of 8 microg/ml but a MIC(50) of 4 microg/ml (intermediate). After pefloxacin infusion, adequate drug plasma levels (>MIC(90)) for the most frequent pathogens were found throughout the procedure. Elimination half-life was estimated as 22.03+/-6.91 h; the area under the concentration-time curve from zero to infinite had a value of 275.07+/-130.02 mg h/l and the values for volume of distribution at steady-state and plasma clearance were 96.48+/-28.65 L and 3.60+/-1.83 l/h, respectively. Bile pefloxacin concentrations generally exceeded the minimum inhibitory concentrations for most relevant pathogens. Drug levels in gallbladder and subcutaneous tissues were also above the MIC(90) for extended periods. Patients were observed daily throughout their hospital stay. This included examination of the surgical wound and recording of body temperature. No cases of anaerobic infection were noted in the study patients. Other constants such as hospitalization stay and time of recuperation were normal for this type of surgery. According to these results, pefloxacin presents many features that make it suitable for use as a therapeutic prophylactic agent, such as its broad spectrum of antimicrobial activity and favorable pharmacokinetic properties." @default.
- W2065131102 created "2016-06-24" @default.
- W2065131102 creator A5037711682 @default.
- W2065131102 creator A5059097260 @default.
- W2065131102 creator A5068230147 @default.
- W2065131102 creator A5069108786 @default.
- W2065131102 creator A5070577695 @default.
- W2065131102 creator A5076443076 @default.
- W2065131102 creator A5088004809 @default.
- W2065131102 date "2002-09-20" @default.
- W2065131102 modified "2023-09-24" @default.
- W2065131102 title "Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery" @default.
- W2065131102 cites W1486807157 @default.
- W2065131102 cites W1876351565 @default.
- W2065131102 cites W1968544791 @default.
- W2065131102 cites W1978116032 @default.
- W2065131102 cites W1982491167 @default.
- W2065131102 cites W1983076976 @default.
- W2065131102 cites W1984086660 @default.
- W2065131102 cites W2000611389 @default.
- W2065131102 cites W2010254139 @default.
- W2065131102 cites W2011830407 @default.
- W2065131102 cites W2028366258 @default.
- W2065131102 cites W2028804851 @default.
- W2065131102 cites W2032381830 @default.
- W2065131102 cites W2036487127 @default.
- W2065131102 cites W2042267629 @default.
- W2065131102 cites W2043526487 @default.
- W2065131102 cites W2048307615 @default.
- W2065131102 cites W2059766503 @default.
- W2065131102 cites W2069958844 @default.
- W2065131102 cites W2086937180 @default.
- W2065131102 cites W2113973140 @default.
- W2065131102 cites W2118027160 @default.
- W2065131102 cites W2133170260 @default.
- W2065131102 cites W2138984944 @default.
- W2065131102 cites W2139261460 @default.
- W2065131102 cites W2147264575 @default.
- W2065131102 cites W2211146491 @default.
- W2065131102 cites W2281923631 @default.
- W2065131102 cites W2502670554 @default.
- W2065131102 doi "https://doi.org/10.1002/bdd.321" @default.
- W2065131102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12355580" @default.
- W2065131102 hasPublicationYear "2002" @default.
- W2065131102 type Work @default.
- W2065131102 sameAs 2065131102 @default.
- W2065131102 citedByCount "2" @default.
- W2065131102 crossrefType "journal-article" @default.
- W2065131102 hasAuthorship W2065131102A5037711682 @default.
- W2065131102 hasAuthorship W2065131102A5059097260 @default.
- W2065131102 hasAuthorship W2065131102A5068230147 @default.
- W2065131102 hasAuthorship W2065131102A5069108786 @default.
- W2065131102 hasAuthorship W2065131102A5070577695 @default.
- W2065131102 hasAuthorship W2065131102A5076443076 @default.
- W2065131102 hasAuthorship W2065131102A5088004809 @default.
- W2065131102 hasConcept C112705442 @default.
- W2065131102 hasConcept C139254425 @default.
- W2065131102 hasConcept C176947019 @default.
- W2065131102 hasConcept C2778049240 @default.
- W2065131102 hasConcept C2778512257 @default.
- W2065131102 hasConcept C2781166304 @default.
- W2065131102 hasConcept C4937899 @default.
- W2065131102 hasConcept C501593827 @default.
- W2065131102 hasConcept C71924100 @default.
- W2065131102 hasConcept C86803240 @default.
- W2065131102 hasConcept C89423630 @default.
- W2065131102 hasConcept C98274493 @default.
- W2065131102 hasConceptScore W2065131102C112705442 @default.
- W2065131102 hasConceptScore W2065131102C139254425 @default.
- W2065131102 hasConceptScore W2065131102C176947019 @default.
- W2065131102 hasConceptScore W2065131102C2778049240 @default.
- W2065131102 hasConceptScore W2065131102C2778512257 @default.
- W2065131102 hasConceptScore W2065131102C2781166304 @default.
- W2065131102 hasConceptScore W2065131102C4937899 @default.
- W2065131102 hasConceptScore W2065131102C501593827 @default.
- W2065131102 hasConceptScore W2065131102C71924100 @default.
- W2065131102 hasConceptScore W2065131102C86803240 @default.
- W2065131102 hasConceptScore W2065131102C89423630 @default.
- W2065131102 hasConceptScore W2065131102C98274493 @default.
- W2065131102 hasIssue "7" @default.
- W2065131102 hasLocation W20651311021 @default.
- W2065131102 hasLocation W20651311022 @default.
- W2065131102 hasOpenAccess W2065131102 @default.
- W2065131102 hasPrimaryLocation W20651311021 @default.
- W2065131102 hasRelatedWork W18378417 @default.
- W2065131102 hasRelatedWork W18383156 @default.
- W2065131102 hasRelatedWork W1995956539 @default.
- W2065131102 hasRelatedWork W2017838353 @default.
- W2065131102 hasRelatedWork W2036692625 @default.
- W2065131102 hasRelatedWork W2072769436 @default.
- W2065131102 hasRelatedWork W2410388087 @default.
- W2065131102 hasRelatedWork W2463077557 @default.
- W2065131102 hasRelatedWork W2980927461 @default.
- W2065131102 hasRelatedWork W72306757 @default.
- W2065131102 hasVolume "23" @default.
- W2065131102 isParatext "false" @default.
- W2065131102 isRetracted "false" @default.
- W2065131102 magId "2065131102" @default.